Table 2. Sclerostin levels with different types of fungi in CD patients.
|
Fungus types |
Count of patients |
Sclerostin levels |
|
Candida albicans |
1 |
1.641 |
|
Candida tropicalis |
1 |
0 |
|
Candida glabrata |
2 |
0 |
|
Pencillium |
1 |
0 |
|
Candida tropicalls, Asprgillus |
1 |
0.11 |
|
Candida albicans, Asprgillus, Fussarium |
4 |
0.136 |
|
Candida albicans, Asprgillus, Pencillium |
3 |
0.128 |
|
Candida glabrata, Pencillium, Mucor |
4 |
0.019 |
|
Candida glabrata, Aspirgillus |
6 |
1.206 |
|
Candida glabrata, Mucor, Rhizopus |
4 |
0.188 |
|
Candida albicans, Asprgillus |
5 |
0 |
|
Candida albicans, Pencillium, Saccharomyces |
4 |
0.244 |
|
Candida glabrata, Asprgillus, Cryptococcus |
4 |
0.283 |
|
Aspirgillus, Trichophyton |
2 |
0 |
|
Candida gulliermondi, Mucor |
5 |
1.140 |
|
Candida glabrata, Pencillium |
4 |
1.320 |
|
Mucor, Saccharomyces |
4 |
0.195 |
|
Saccharomyces |
5 |
0 |
|
Mean±S.E. |
|
1.14±0.34 |
|
T test |
|
3.326 |
|
P-value |
|
0.05* |
The data represented serum sclerostin levels in different fungal species compared to one another in CD patients. *Significant at probability level p≤0.05